Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 69.51 M82.89 M83.3 M93.59 M 329.29 M Research & development ———— — Operating income 249.18 M123.87 M35.94 M-58.81 M 350.19 M Non-Operating Income, Total 14.08 M12.21 M22.24 M12.29 M 60.82 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 12.85 M12.27 M22.94 M9.79 M 57.84 M Unusual income/expense 1.23 M-56 K-696 K2.49 M 2.97 M Pretax income 263.26 M136.08 M58.19 M-46.53 M 411 M Equity in earnings ———-825 K — Taxes 64.16 M33.15 M7.07 M-11.49 M 92.89 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 199.34 M102.76 M50.46 M-35.88 M 316.68 M Discontinued operations ———— — Net income 199.34 M102.76 M50.46 M-35.88 M 316.68 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 199.34 M102.76 M50.46 M-35.88 M 316.68 M Basic earnings per share (Basic EPS) 4.132.141.07-0.69 6.65 Diluted earnings per share (Diluted EPS) 4.122.131.06-0.68 6.63 Average basic shares outstanding 48.28 M48.02 M47.3 M47.65 M — Diluted shares outstanding 48.42 M48.17 M47.41 M47.78 M — EBITDA 284.21 M166.24 M77.26 M-32.38 M 495.33 M EBIT 254.55 M136.13 M46.73 M-66.43 M 370.99 M Cost of revenue 611.29 M562.11 M547.67 M518.51 M 2.24 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 29.66 M30.11 M30.52 M34.05 M 124.34 M